As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.
Navigating the Evolving Pharma Landscape: A Year in Review
read more
BLOG
Revolutionizing Patient Care: The Top 5 Benefits of Investing in Innovation
Why manufacturers must embrace innovative trends to stay ahead
Digital Solutions in Patient Services
An Interview on Best Practices and Trends in 2025
Designing a Pharma Hub for Combination Products
Designing a pharmaceutical hub for combination or companion products is a complex undertaking that requires careful planning and design execution.
How To Maximize Biotech Vendor Marketing
Biotech marketing requires a unique blend of scientific expertise, strategic planning, and creative execution.
Keep Your Planning in the Driver’s Seat: Review Your 2025 Patient Services Strategy Now
Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.
What to Do When Your Brand Sees a Sudden Rise in Copay Costs
What to Do When Your Brand Sees a Sudden Rise in Copay Costs
Essential Takeaways from the 2024 ECRM Conference
Essential Takeaways from the 2024 ECRM Conference
Hub Implementation: The Key to Product Launches
Hub Implementation: The Key to Product Launches
Revving Up for 2024: Market Access Kick-Start Resources
Revving Up for 2024: Market Access Kick-Start Resources
Key Market Access Trends to Watch in 2024
Key Market Access Trends to Watch in 2024
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
The Key to Pharmaceutical Commercial Success
The Key to Pharmaceutical Commercial Success
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
Webinar Archive: Pharmaceutical HUBs are Underutilized; Yours Doesn’t Have to Be
HUBs are Underutilized; Yours Doesn’t Have to Be
How Product Acquisition Impacts Patient Support Offerings: Buy and Bill vs. Specialty Pharmacy
Product Acquistion (Buy and Bill vs. Specialty Pharmacy) is a key factor in determining which services a HUB should offer
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
How Manufacturers Can Optimize Hub Services
How Manufacturers Can Optimize Hub Services
Best Practices for Vendor Selection and Management
Best Practices for Vendor Selection and Management
10 Market Access Trends to Watch for in 2023
Our experts teamed up with Pharmaceutical Executive to identify 10 Market Access Trends to Watch for in 2023, spanning patients, prescribers
Well-designed Access and Affordability Programs can be a Key Differentiator for Pharma Companies
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Webinar Archive: Get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
10 Steps to Building an Integrated Pharmaceutical Launch Strategy
The key to building an integrated model for new products is understanding which steps in launch planning are essential and when to take them
How Patient Support Programs Can Compliantly Interact with Commercial Teams
With the right approach, patient support programs can mitigate the potential negative impacts of regulatory compliance
Effective and Practical Ways to Impact Health Inequity Now
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
Want to Build a Market-Leading Pharmaceutical Patient Support Program? Ask a Nurse.
In celebration of Nurses Day, explore how nurses working for pharmaceutical consulting companies benefit manufacturers’ commercial goals
How Quality in Patient Services Programs Can be a Powerful Differentiator for Pharma and Biotech
Poor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking alternative avenues.
What the CMS Final Rule on Copay Programs Means for Pharmaceutical Manufacturers
It is vital for pharmaceutical manufacturers to consider how much financial and reputational risk they may face as a result of the pending C
Advice for New Patient Services Leaders
A seasoned patient services leader offers guidance on where to focus, how to best align resources, and when and where to ask for help.